Eargo Inc Receivables Turnover Ratio (EAR), from the third quarter 2023 to the third quarter 2022 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Eargo Inc   (NASDAQ: EAR)
 

Eargo Inc Accounts Receivables Turnover Ratio from the third quarter 2023 to the third quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Eargo Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2023 to a ratio of 27.36, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the third quarter 2023. Average collection period, for Eargo Inc 's accounts receivable remained unchanged at 13 days, in the Sep 30 2023 quarter.

If we take a look into Healthcare sector 357 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2023 from 2500 to 2596.

What is Receivable Turnover Ratio?
What is Eargo Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EAR Receivables Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Receivable Change -12.46 % -92.15 % -84.33 % -84.78 % -92.27 %
Y / Y Revenue Change -7.27 % 5.3 % 28.74 % - -
Receivable Turnover Ratio (TTM) 27.36 27.09 9.26 5.41 -
EAR's Total Ranking # 2596 # 2500 # 943 # 1958 # 0
Accounts Receivable average collection period days 13 13 39 68 -
Seq. Receivable Change 5.31 % -49.95 % 0.52 % 65.22 % -90.55 %
Seq. Revenue Change -3.91 % -35.4 % -8.55 % 63.34 % 9.12 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 140
Healthcare Sector # 358
Overall Market # 2596

Receivable Turnover Ratio Statistics
High Average Low
0.55 0.11 -0.46
(Mar 31 2021)   (Jun 30 2022)





EAR Company Profile • Back to EAR Efficiency Comparisons • Compare EAR Receivables Turnover Ratio to its Competitors

Financial Statements
Eargo Inc 's Accounts Receivable $ 1 Millions Visit EAR's Balance sheet
Eargo Inc 's Sales TTM $ 40 Millions Visit EAR's Income Statement
Sources of EAR's Revenues Visit EAR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
EAR's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
EAR's Growth Rates EAR's Roa EAR's Inventory Turnover Ratio EAR's Dividend Comparisons
EAR's Profitability Ratios EAR's Roi EAR's Asset Turnover Ratio EAR's Dividend Growth
EAR's Valuation Ratios EAR's Roe EAR's Financial Strength Ratios EAR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Receivable at quarter ending Sep 30 2023
Fonar Corporation  104.93 $ 101.292  Millions$ 0.965  Millions
Prothena Corporation Public Limited Company  99.23 $ 140.977  Millions$ 1.421  Millions
Orthofix Medical Inc   98.14 $ 667.747  Millions$ 6.804  Millions
Lifevantage Corp  86.64 $ 212.421  Millions$ 2.452  Millions
Logicmark Inc  80.11 $ 9.650  Millions$ 0.120  Millions
Alpine Immune Sciences Inc   78.82 $ 30.799  Millions$ 0.391  Millions
Tango Therapeutics Inc   75.01 $ 37.507  Millions$ 0.500  Millions
Pavmed Inc   63.57 $ 1.923  Millions$ 0.030  Millions
Scynexis Inc   62.10 $ 135.869  Millions$ 2.188  Millions
Clearday Inc   61.82 $ 7.543  Millions$ 0.122  Millions
Agenus Inc  61.81 $ 100.897  Millions$ 1.632  Millions
Lucid Diagnostics Inc   60.00 $ 1.500  Millions$ 0.025  Millions
Brookdale Senior Living Inc   57.81 $ 2,949.838  Millions$ 51.031  Millions
Embecta Corp   56.63 $ 1,119.900  Millions$ 19.775  Millions
Aridis Pharmaceuticals Inc   55.31 $ 22.359  Millions$ 0.404  Millions
Sangamo Therapeutics Inc   55.30 $ 201.420  Millions$ 3.642  Millions
Ambrx Biopharma Inc   53.68 $ 8.602  Millions$ 0.160  Millions
Vireo Growth Inc.  50.94 $ 83.003  Millions$ 1.629  Millions
Rosecliff Acquisition Corp I  49.74 $ 16.315  Millions$ 0.328  Millions
Wave Life Sciences Ltd   48.85 $ 85.488  Millions$ 1.750  Millions
Janux Therapeutics Inc   45.16 $ 8.467  Millions$ 0.188  Millions
Ngm Biopharmaceuticals Inc   45.02 $ 22.433  Millions$ 0.498  Millions
Aclaris Therapeutics Inc   44.03 $ 21.432  Millions$ 0.487  Millions
Orchestra Biomed Holdings Inc   43.26 $ 3.601  Millions$ 0.083  Millions
Vivos Therapeutics Inc   41.42 $ 13.803  Millions$ 0.333  Millions
Vbi Vaccines Inc  40.26 $ 8.122  Millions$ 0.202  Millions
Lineage Cell Therapeutics Inc   40.10 $ 8.772  Millions$ 0.219  Millions
Arvinas Inc   39.81 $ 167.200  Millions$ 4.200  Millions
Lifemd Inc   38.75 $ 134.262  Millions$ 3.465  Millions
Caribou Biosciences Inc   38.10 $ 34.611  Millions$ 0.909  Millions

Date modified: 2026-10-07T00:41:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.